3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Unknown
1
Enrolling by invitation
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
5
Other hematologic neoplasm
2
Genitourinary
2
Thoracic
1
Plasma cell
1
Gastrointestinal
1
Breast
1
Conditions
Colorectal Neoplasms
1057
Stomach Neoplasms
802
Carcinoma, Hepatocellular
785
Pancreatic Neoplasms
577
Rectal Neoplasms
449
Colonic Neoplasms
405
Esophageal Neoplasms
363
Liver Neoplasms
225
Esophageal Squamous Cell Carcinoma
144
Neoplasms
134
Cholangiocarcinoma
129
Neoplasm Metastasis
117
Breast Neoplasms
117
Gastrointestinal Neoplasms
105
Lung Neoplasms
76
Biliary Tract Neoplasms
73
Recurrence
61
Prostatic Neoplasms
52
Ovarian Neoplasms
49
Barrett Esophagus
47
Carcinoma, Non-Small-Cell Lung
44
Anastomotic Leak
43
Bile Duct Neoplasms
42
Gastrointestinal Stromal Tumors
40
Gallbladder Neoplasms
40
Head and Neck Neoplasms
38
Digestive System Neoplasms
35
Anus Neoplasms
34
Colonic Polyps
33
Adenocarcinoma Of Esophagus
32
Interventions
palbociclib
1
Rivaroxaban
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Immune System Diseases
×
Gastrointestinal
×
Clear all
NCT06065592
2023-10-06
CAT_PB
Lebanese University
Phase 1
Unknown
500 enrolled